The landscape of dementia analysis has advanced substantially with the appearance of innovative biomarkers, including amyloid PET scans, tau imaging, and blood-based mostly checks that may detect Alzheimer's pathology several years before signs arise. Though these technological advances symbolize extraordinary development in comprehending neurodege